Free Trial

BlackRock Capital Allocation Term Trust (BCAT) Competitors

BlackRock Capital Allocation Term Trust logo
$14.82 -0.08 (-0.54%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$14.82 -0.01 (-0.03%)
As of 08/1/2025 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BCAT vs. FSK, DNP, ADX, PTY, GAB, RVT, NUV, STEW, OXLC, and CET

Should you be buying BlackRock Capital Allocation Term Trust stock or one of its competitors? The main competitors of BlackRock Capital Allocation Term Trust include FS KKR Capital (FSK), DNP Select Income Fund (DNP), Adams Diversified Equity Fund (ADX), Pimco Corporate & Income Opportunity Fund (PTY), Gabelli Equity Trust (GAB), Royce Small-Cap Trust (RVT), Nuveen Municipal Value Fund (NUV), SRH Total Return Fund (STEW), Oxford Lane Capital (OXLC), and Central Securities (CET). These companies are all part of the "financial services" industry.

BlackRock Capital Allocation Term Trust vs. Its Competitors

FS KKR Capital (NYSE:FSK) and BlackRock Capital Allocation Term Trust (NYSE:BCAT) are both financial services companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation.

36.3% of FS KKR Capital shares are owned by institutional investors. Comparatively, 36.1% of BlackRock Capital Allocation Term Trust shares are owned by institutional investors. 0.2% of FS KKR Capital shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

FS KKR Capital currently has a consensus target price of $19.50, indicating a potential downside of 4.79%. Given FS KKR Capital's stronger consensus rating and higher probable upside, equities analysts clearly believe FS KKR Capital is more favorable than BlackRock Capital Allocation Term Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FS KKR Capital
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.83
BlackRock Capital Allocation Term Trust
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

FS KKR Capital has higher revenue and earnings than BlackRock Capital Allocation Term Trust.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FS KKR Capital$1.72BN/A$585M$1.9010.78
BlackRock Capital Allocation Term Trust$197.67M8.06N/AN/AN/A

FS KKR Capital has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, BlackRock Capital Allocation Term Trust has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500.

FS KKR Capital has a net margin of 31.53% compared to BlackRock Capital Allocation Term Trust's net margin of 0.00%. FS KKR Capital's return on equity of 11.78% beat BlackRock Capital Allocation Term Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
FS KKR Capital31.53% 11.78% 5.27%
BlackRock Capital Allocation Term Trust N/A N/A N/A

FS KKR Capital pays an annual dividend of $2.56 per share and has a dividend yield of 12.5%. BlackRock Capital Allocation Term Trust pays an annual dividend of $3.42 per share and has a dividend yield of 23.1%. FS KKR Capital pays out 134.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, FS KKR Capital had 3 more articles in the media than BlackRock Capital Allocation Term Trust. MarketBeat recorded 3 mentions for FS KKR Capital and 0 mentions for BlackRock Capital Allocation Term Trust. BlackRock Capital Allocation Term Trust's average media sentiment score of 1.21 beat FS KKR Capital's score of 1.07 indicating that BlackRock Capital Allocation Term Trust is being referred to more favorably in the news media.

Company Overall Sentiment
FS KKR Capital Positive
BlackRock Capital Allocation Term Trust Positive

Summary

FS KKR Capital beats BlackRock Capital Allocation Term Trust on 10 of the 13 factors compared between the two stocks.

Get BlackRock Capital Allocation Term Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCAT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BCAT vs. The Competition

MetricBlackRock Capital Allocation Term TrustElectronic Computer Manufacturing IndustryManufacturing SectorNYSE Exchange
Market Cap$1.59B$2.48B$2.21B$20.68B
Dividend Yield22.90%2.56%2.59%3.67%
P/E RatioN/A29.0122.1429.07
Price / Sales8.065.2883.3066.27
Price / CashN/AN/A26.0522.84
Price / BookN/AN/A40.024.43
Net IncomeN/A-$19.32M-$62.28M$994.22M
7 Day Performance-0.97%-1.80%-2.46%-3.35%
1 Month Performance-2.11%-0.37%-0.54%-2.06%
1 Year Performance-8.41%10.36%26.18%10.15%

BlackRock Capital Allocation Term Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BCAT
BlackRock Capital Allocation Term Trust
N/A$14.82
-0.5%
N/A-9.8%$1.59B$197.67M0.00147,000Positive News
FSK
FS KKR Capital
2.0678 of 5 stars
$21.82
-1.8%
$19.50
-10.6%
+2.0%$6.23B$613M11.48N/APositive News
Upcoming Earnings
DNP
DNP Select Income Fund
N/A$9.82
-0.2%
N/A+8.2%$3.64BN/A0.00590News Coverage
Positive News
ADX
Adams Diversified Equity Fund
N/A$21.81
-1.8%
N/A-0.8%$2.61BN/A0.0030Positive News
PTY
Pimco Corporate & Income Opportunity Fund
N/A$13.86
+0.0%
N/A-2.5%$2.52BN/A0.00147,000Positive News
GAB
Gabelli Equity Trust
N/A$5.93
-0.5%
N/A+8.0%$1.83BN/A0.00N/A
RVT
Royce Small-Cap Trust
N/A$15.51
+0.2%
N/A-4.3%$1.79BN/A0.0050High Trading Volume
NUV
Nuveen Municipal Value Fund
N/A$8.51
-0.4%
N/A-2.4%$1.77BN/A0.00640News Coverage
Positive News
STEW
SRH Total Return Fund
N/A$17.74
-0.6%
N/A+15.6%$1.72BN/A0.00N/ANews Coverage
Upcoming Earnings
OXLC
Oxford Lane Capital
2.1336 of 5 stars
$3.70
+2.2%
N/A-37.1%$1.68B$57.31M4.46601Positive News
CET
Central Securities
N/A$48.49
-0.4%
N/A+11.0%$1.40B$296.20M0.006News Coverage

Related Companies and Tools


This page (NYSE:BCAT) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners